Tirzepatide Week-by-Week
Mounjaro & Zepbound Timeline
Week-by-week guide to Mounjaro and Zepbound. What to expect at each dose, typical weight loss timeline, and managing side effects.
Your Tirzepatide Journey
Tirzepatide works on both GLP-1 and GIP receptors, often producing faster results than semaglutide alone.
Mounjaro vs Zepbound
Same medication, different indication. Both are tirzepatide made by Eli Lilly. The only difference is FDA approval:
The timeline above applies to both. Insurance coverage may differ based on which is prescribed.
Mounjaro: Approved for Type 2 diabetes. Zepbound: Approved for chronic weight management.
Why Track This Protocol
Guide FAQs
Week-by-week guide to Mounjaro and Zepbound. What to expect at each dose, typical weight loss timeline, and managing side effects.
Yes. Shotlee supports tracking Tirzepatide Week By Week doses, side effects, and health metrics. It is free.
Track Your Tirzepatide Week By Week Protocol in Shotlee
Free dose logging, side effect tracking, and health metric monitoring for your complete protocol.
📚References & sources
Latest on Tirzepatide Week By Week
Anandita Sundar's 7-Year Weight Loss Journey and Body Shaming
Anandita Sundar opens up about her seven-year weight loss journey, highlighting the profound impact of body shaming on mental health and her commitment to prioritizing well-being over societal expectations.
7 min read
Plus-Size Swimsuit Model on Inclusivity Amidst GLP-1 Medications
Plus-size model Hunter McGrady shares her concerns about a perceived decline in fashion inclusivity, particularly in the context of the growing popularity of GLP-1 weight loss medications.
7 min read
Black-Market Peptide Surge Strains Needle and Syringe Programs
The rise of unregulated peptides for performance and image enhancement is placing significant pressure on vital harm reduction services, originally established to combat HIV. These programs are now facing increased demand and potential shortages of essential supplies.
7 min read